The placental factor in early- and late-onset normotensive fetal growth restriction

被引:78
|
作者
Kovo, M. [1 ,4 ]
Schreiber, L. [2 ,4 ]
Ben-Haroush, A. [3 ,4 ]
Cohen, G. [1 ,4 ]
Weiner, E. [1 ,4 ]
Golan, A. [1 ,4 ]
Bar, J. [1 ,4 ]
机构
[1] Edith Wolfson Med Ctr, Dept Obstet & Gynecol, IL-58100 Holon, Israel
[2] Edith Wolfson Med Ctr, Dept Pathol, IL-58100 Holon, Israel
[3] Rabin Med Ctr, Dept Obstet & Gynecol, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
Fetal growth restriction; Early-onset; Late-onset; Placenta; Histopathology; UMBILICAL ARTERY DOPPLER; GESTATIONAL-AGE FETUSES; PREMATURE RUPTURE; BLOOD-FLOW; PREECLAMPSIA; PATHOLOGY; LESIONS; BIRTH;
D O I
10.1016/j.placenta.2012.11.010
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Our objective was to investigate the placental component in early- and late-onset fetal growth restriction (FGR) compared to placentas from neonates appropriate for gestational age (AGA). Study design: Placentas from normotensive women who gave birth at 24-42 weeks to neonates with a birth-weight below the 10th percentile (FGR group), or to healthy AGA neonates (AGA group), were analyzed. Placental lesions were classified to lesions related to maternal underperfusion, lesions consistent with fetal thrombo-occlusive disease and inflammatory lesions. Findings were compared between patients who delivered <= 34 weeks (early-onset FGR) or >34 weeks (late-onset FGR) and controls with AGA neonates. Results: The early-onset FGR group (n = 24) had a higher rate of placental vascular lesions related to maternal underperfusion than the late-FGR group (n = 334) (41.7% vs. 8.7%, P < 0.001) and more villous lesions related to maternal underperfusion than the preterm AGA group (n = 68) (70.8% vs. 5.9%, P < 0.001). The late-onset FGR group had more placental villous lesions related to maternal underperfusion (57% vs. 19% P < 0.001) and more lesions consistent with fetal thrombo-occlusive disease (26.3% vs. 8.5%, P < 0.001) than the term AGA group (n = 153). Conclusion: Early- and late-onset FGR have different placental pathology compared with AGA controls, suggesting that a combination of fetal and maternal vascular compromise is more dominant in the late-onset FGR, rather than more severe maternal vascular compromise in early-onset FGR. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 50 条
  • [31] Assessment of fetal cardiac morphology and functional changes in early-onset and late-onset fetal growth restriction
    Oluklu, Deniz
    Beser, Dilek Menekse
    Hendem, Derya Uyan
    Yildirim, Muradiye
    Koc, Bergen Laleli
    Tanacan, Atakan
    Sahin, Dilek
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 161 (01) : 241 - 249
  • [32] Placental histopathology in preterm fetal growth restriction
    Sehgal, Arvind
    Dahlstrom, Jane E.
    Chan, Yuen
    Allison, Beth J.
    Miller, Suzanne L.
    Polglase, Graeme R.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (05) : 582 - 587
  • [33] Clinical Correlates of Placental Pathologic Features in Early-Onset Fetal Growth Restriction
    Spinillo, Arsenio
    Meroni, Anna
    Melito, Chiara
    Scatigno, Annachiara Licia
    Tzialla, Chryssoula
    Fiandrino, Giacomo
    Cesari, Stefania
    Gardella, Barbara
    FETAL DIAGNOSIS AND THERAPY, 2022, 49 (5-6) : 215 - 224
  • [34] Management of late-onset fetal growth restriction: pragmatic approach
    Peasley, R.
    Rangel, L. A. Abrego
    Casagrandi, D.
    Donadono, V.
    Willinger, M.
    Conti, G.
    Seminara, Y.
    Marlow, N.
    David, A. L.
    Attilakos, G.
    Pandya, P.
    Zaikin, A.
    Peebles, D.
    Napolitano, R.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2023, 62 (01) : 106 - 114
  • [35] Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia
    Marloes Dekker Nitert
    Katherin Scholz-Romero
    Marta H Kubala
    H David McIntyre
    Leonie K Callaway
    Helen L Barrett
    Reproductive Biology and Endocrinology, 13
  • [36] Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia
    Nitert, Marloes Dekker
    Scholz-Romero, Katherin
    Kubala, Marta H.
    McIntyre, H. David
    Callaway, Leonie K.
    Barrett, Helen L.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
  • [37] Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation
    Whitehead, Clare L.
    McNamara, Helen
    Walker, Susan P.
    Alexiadis, Maria
    Fuller, Peter J.
    Vickers, Daniel K.
    Hannan, Natalie J.
    Hastie, Roxanne
    Tuohey, Laura
    Kaitu'u-Lino, Tu'uhevaha J.
    Tong, Stephen
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (04) : 521.e1 - 521.e8
  • [38] Clinical outcome and placental characteristics of monochorionic diamniotic twin pairs with early- and late-onset discordant growth
    Lewi, Liesbeth
    Gucciardo, Leonardo
    Huber, Agnes
    Jani, Jacques
    Van Mieghem, Tim
    Done, Elisa
    Cannie, Mieke
    Gratacos, Eduardo
    Diemert, Anke
    Hecher, Kurt
    Lewi, Paul
    Deprest, Jan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (05) : 511.e1 - 511.e7
  • [39] Can Inflammatory Hematological Parameters be a Guide to Late-onset Fetal Growth Restriction?
    Kirmizi, Demet Aydogan
    Baser, Emre
    Onat, Taylan
    Caltekin, Melike Demir
    Kara, Mustafa
    Yalvac, Ethem Serdar
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2020, 224 (05): : 262 - 268
  • [40] Adverse perinatal outcomes in fetuses with severe late-onset fetal growth restriction
    Rozo Bahia, Maria Luiza
    Velarde, Guillermo Coca
    da Silva, Fernanda Campos
    Araujo Junior, Edward
    Moreira de Sa, Renato Augusto
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25) : 8666 - 8672